Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×
Synergy Pharmaceuticals, Inc.
Commercial Physical And Biological Research NY, United States
Nasdaq: SGYP | Nasdaq: SGYPW | Nasdaq: SGYPU
Company Description
Synergy Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of drugs to treat gastrointestinal disorders and diseases. Its proprietary drug candidate Plecanatide is a synthetic analog of the human gastrointestinal hormone uroguanylin, and functions by activating the Guanylate Cyclase C receptor on epithelial cells of the GI tract. The company was founded on November 15, 2005 and is headquartered in New York, NY.
Similar to: Medivir AB, Advanced Cell Technology, Inc., Exelixis, Inc.
Featured Company
Fidelity Asian Values Plc
Tadworth, SU, GB
Fidelity Asian Values Plc is a Closed-End Investment Fund/Investment. The company invests in information technology, energy, financial… Learn more →
Social Monitor
You may also be interested in:
Exelixis, Inc.
South San Francisco, CA, US
Exelixis, Inc. develops human therapeutics by innovating therapies for cancer and other serious diseases to various pharmaceutical… Learn more →
Advanced Cell Technology,…
Marlborough, MA, US
Advanced Cell Technology, Inc. is a biotechnology company that develops cellular therapies for the treatment of rare and common diseases… Learn more →
Medivir AB
Stockholm, SE
Medivir is a research based pharmaceutical company focused on infectious diseases and Nordic market presences were we market 15 products… Learn more →